BioSpace News Archive

BioMidwest

Inspired Spine: Self-Reported Female Orgasm Following Serial Sacroiliac Joint Injections

Inspired Spine has announced an unusual but interesting medical finding after a patient received a sacroiliac joint injection and experienced the longest orgasm of her life.

November 30, 2021
·
1 min read
Genetown

nference Study Produces First Molecular Hypothesis Explaining COVID-19-Induced Myocarditis

nference, the AI-driven health technology company, today announced publication of a preprint study in bioRxiv that found the genetic alteration of some linear peptides expressed specifically in the human heart are mimicked by the SARS-CoV-2 polyprotein (replicase).

November 30, 2021
·
2 min read
BioCapital

Immunomic Therapeutics Announces Open Enrollment for RENEW Clinical Study of CMV RNA-Pulsed Dendritic Cell Vaccine for the Treatment of Newly-Diagnosed Glioblastoma Patients

Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical-stage biotechnology company pioneering the study of LAMP-mediated nucleic acid-based immunotherapy, announced the opening of a new clinical study in collaboration with Dr. Duane Mitchell at the University of Florida.

November 30, 2021
·
5 min read
BioMidwest

Zimmer Biomet Announces Pricing of its Tender Offers for Certain Outstanding Debt Securities

Approximately $211.48 million in aggregate principal amount of Any and All Notes were validly tendered and not validly withdrawn prior to 5:00 p.m., New York City time, on November 29, 2021 and will be accepted for purchase on the Early Settlement Date.

November 30, 2021
·
9 min read
Business

Merck Announces First-Quarter 2022 Dividend

Merck, known as MSD outside the United States and Canada, announced that the Board of Directors has declared a quarterly dividend of $0.69 per share of the company’s common stock for the first quarter of 2022.

November 30, 2021
·
3 min read
Business

Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2022 After Market Close on December 7, 2021

Avid Bioservices, Inc. (NASDAQ:CDMO), today announced that it will report financial results for the second quarter of fiscal year 2022 on December 7, 2021 after market close and will host a conference call and webcast at 1:30 PM Pacific Time (4:30 PM Eastern Time).

November 30, 2021
·
1 min read
Biotech Beach

MEI Pharma Announces Proposed Public Offering of Common Stock - Nov 30, 2021

MEI Pharma, Inc., a late-stage pharmaceutical company focused on advancing new therapies for cancer, announced that it plans to offer 17,500,000 shares of its common stock in an underwritten public offering.

November 30, 2021
·
4 min read
Drug Development

Blade Therapeutics Announces Positive Topline Data from Phase 1 Clinical Study of Cudetaxestat, a Non-Competitive Autotaxin Inhibitor in Clinical Development for Idiopathic Pulmonary Fibrosis

Blade Therapeutics, Inc. today announced positive topline data from a phase 1 drug-drug interaction clinical study of cudetaxestat, an investigational non-competitive autotaxin inhibitor in clinical development for IPF.

November 30, 2021
·
5 min read
BioMidwest

Virtual Incision Announces $46 Million Financing to Advance First-of-its-Kind MIRA Surgical Platform

Virtual Incision Corporation, a medical device company pioneering first-of-its-kind miniaturized robots for laparoscopic surgery, announced it has raised $46 million in a Series C funding round.

November 30, 2021
·
5 min read
Genetown

Macular Therapeutics, Inc. Announces Issuance of Three U.S. Patents for Methods to Treat Macular Degeneration Using Botulinum-Based Neuromodulators

Macular Therapeutics, Inc. today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 11,096,993, U.S. Patent No. 11,123,411 U.S. Patent No. 11,123,412 each entitled “Method of Treating Macular Degeneration Using Botulinum-Based Neuromodulators.

November 30, 2021
·
2 min read